Evaluating the role of amitriptyline in chronic temporomandibular disorder management: a placebo-controlled trial

ISRCTN ISRCTN17622685
DOI https://doi.org/10.1186/ISRCTN17622685
Secondary identifying numbers No. IP-2014-09-3070, 643-03/19-02/33
Submission date
26/09/2024
Registration date
01/10/2024
Last edited
05/03/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
The study will aim to assess the effectiveness of low-dose amitriptyline in reducing pain and improving oral health-related quality of life in individuals with chronic temporomandibular disorders (TMD) over 2 months, compared to a placebo.

Who can participate?
Everyone who meets the inclusion criteria will be eligible to participate in the study.

What does the study involve?
Participants will receive either low-dose amitriptyline or a placebo. The study will compare the effects of the medication on pain reduction and quality of life improvement.

What are the possible benefits and risks of participating?
Participants may experience a reduction in pain and an improvement in quality of life. However, the medication may have side effects, including potential mood changes.

Where is the study run from?
School of Dental Medicine, University of Zagreb

When is the study starting and how long is it expected to run for?
June 2015 to June 2018

Who is funding the study?
Investigator initiated and funded
Croatian Science Foundation

Who is the main contact?
Iva Ž. Alajbeg, ialajbeg@sfzg.hr

Contact information

Prof Iva Ž. Alajbeg
Public, Scientific, Principal Investigator

Gundulićeva 5
Zagreb
10000
Croatia

ORCiD logoORCID ID 0000-0001-8524-5661
Phone +38514802125
Email ialajbeg@sfzg.hr

Study information

Study designInterventional double-blind study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Dental clinic
Study typeQuality of life, Treatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleTemporomandibular chronic disorder, amitriptyline, splint therapy, pain reduction
Study hypothesisPatients taking low-dose amitriptyline will have lower pain and improved quality of life compared to those taking active placebo.
Ethics approval(s)

Approved 15/09/2015, Ethics Committee of the University of Zagreb School of Dental Medicine (Petrinjska 34, Zagreb, 10000, Croatia; +385 014802111; dekanat@sfzg.hr), ref: 01-PA-26-6/15

ConditionOrofacial pain due to chronic temporomandibular disorder
InterventionPatients will be recruited from the Institute for Mobile Prosthetics, Faculty of Dentistry in Zagreb. Patients with pain lasting longer than 3 months and caused by a temporomandibular disorder will be sought. Patients will sign an informed consent to participate. Two researchers will examine the patients using the Croatian version of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). The Visual Analogue Scale (VAS) will be used to determine the intensity of pain, and the Oral Health Impact Profile-14 (OHIP-14) will assess the quality of life. Patients will receive either amitriptyline at a dose of 25 mg or a placebo. The medicine and the placebo will be packed in the medicine factory at random with the help of a computer program in identical bottles with numbers. What is in each bottle will be recorded on a list that the researchers will open at the end of the research. The vial each patient receives is also assigned by a computer program. Patients will be followed up at 4 and 8 weeks, and VAS and OHIP-14 will be measured each time.
Intervention typeDrug
Pharmaceutical study type(s)Pharmacodynamic
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Amitriptilin
Primary outcome measureThe following primary outcome measures will be assessed at baseline and weeks 4 and 8:
1. Pain measured using the Visual Analogue Scale (VAS)
2. Quality of life measured using the Oral Health Impact Profile-14 (OHIP-14)
Secondary outcome measuresThere are no secondary measures
Overall study start date15/06/2015
Overall study end date19/06/2018

Eligibility

Participant type(s)Patient
Age groupMixed
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants30
Total final enrolment40
Participant inclusion criteria1. Patients aged between 18 and 70 years old
2. Orofacial pain lasting longer than 3 months
3. A VAS outcome above 30 mm
4. Caused by a temporomandibular disorder
Participant exclusion criteria1. Periodontal diseases
2. Partial dentures
3. Extensive fixed prosthetic works
4. Orthodontic braces
5. Mental or neurological disorders
6. Pregnancy
7. Heart disease
8. Drug allergy
Recruitment start date21/09/2015
Recruitment end date24/04/2018

Locations

Countries of recruitment

  • Croatia

Study participating centre

Faculty of Dentistry in Zagreb, University of Zagreb
Gundulićeva 5
Zagreb
10000
Croatia

Sponsor information

University of Zagreb
University/education

Faculty of Dentistry in Zagreb, Gundulićeva 5
Zagreb
10 000
Croatia

Phone +385-1-4802-111
Email dekanat@sfzg.hr
Website https://www.sfzg.unizg.hr/
ROR logo "ROR" https://ror.org/00mv6sv71

Funders

Funder type

Other

Investigator initiated and funded

No information available

Croatian Science Foundation

No information available

Results and Publications

Intention to publish date25/09/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planDatasets generated during the study will be available upon request to the researcher, Ratka Borić Brakus, ratka.boric@gmail.com. Research results obtained from statisticians can be obtained.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 04/03/2025 05/03/2025 Yes No

Editorial Notes

05/03/2025: Publication reference added.
01/10/2024: Study's existence confirmed by the University of Zagreb, Faculty of Dentistry in the Republic of Croatia.